Viatris Inc. (VTRS) は上場企業です ヘルスケア セクターの Drug Manufacturers - Specialty & Generic 業界で事業展開. 本社所在地は Canonsburg, PA, アメリカ. 現CEOは Scott Andrew Smith.
VTRS を有する IPO日 1980-03-17, 32,000 名の正社員, に上場 NASDAQ Global Select, 時価総額 $16.02B.
Viatris Inc. is a global healthcare company headquartered in Canonsburg, Pennsylvania, that develops and distributes a diverse portfolio of prescription brand drugs, generic medications, complex generics, biosimilars, and active pharmaceutical ingredients across four geographic segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company operates across multiple therapeutic areas including noncommunicable and infectious diseases, oncology, immunology, endocrinology, and ophthalmology, offering medicines in various formats such as oral solids, injectables, and complex dosage forms. Viatris markets well-known pharmaceutical brands including Lyrica, Lipitor, EpiPen, Viagra, and Celebrex, along with biosimilar franchises such as Fulphila and SEMGLEE, distributing its products through a broad network of pharmaceutical wholesalers, retailers, specialty pharmacies, and e-commerce channels. Beyond medications, the company provides patient support services including diagnostic clinics, educational seminars, and digital health tools. The company maintains strategic partnerships with leading biotechnology firms to expand its innovative pipeline and global reach.
